Ann: $6.6 million Placement to advance clinical trial pipeline, page-56

Yes but any early investor invested presumably because of the IP and the potential
( in reality most just invested because they thought they were going to make money - end of story )
The facts are

a) The IP has advanced miles more than what it was 3-4 years ago when the share price was 20-30 cents

b) Sure there has been some huge dilution - its a really expensive space to be in .

c) We are where we are ....

d) An existing holder can piss and moan about wanting the price to get back to the level that they invested in etc etc ...and yes that might happen ...it might not ....

or

e) be a bit proactive .... ( and yes I understand different people have different risk profiles ) but IF someone purchased 10,000 CHM back then in the float for say $2000 or what ever ..... they could buy another 10,000 CHM today of $50 - they then have double their original amount of shares .... or for $200 they could have X 5 times their original amount of shares ( thus maintaining the original % holding ( Dont quote me on the maths etc ...the $$ might need to be a bit more )

f) Its all speculative - yeah you could do yr $ doh ( on paper you've basically done it already ) or you might do well

End of story .

Lets hear what Beck MQ has to say tomorrow

GLTAH